laruparetigene zosaparvovec
Phase 2- Indications
- X-linked retinitis pigmentosa (XLRP)
Company intelligence / Profile preview
Applied Genetic Technologies Corporation
Alachua, Florida, United Statesorpha.net ↗
- Ownership
- Private
- Employees
- ~104
- Development stage
- Phase 2
01
Overview
AGTC has multiple programs in clinical development, including Phase 1/2 trials for X-linked retinitis pigmentosa and achromatopsia (CNGB3 or CNGA3 mutations). Positive interim data from Phase 1/2 trials have been reported, including six-month results showing promise in vision improvement.
- Therapeutic areas
- OphthalmologyNeurology
- Modalities
- Gene therapy using Adeno-associated virus (AAV) vectorsOptogeneticsSynthetic promoter technology
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Collaboration with Bionic Sight Inc. on optogenetic therapiesCollaboration with Otonomy Inc., focused on neurotology therapeuticsLicensing agreement with SparingVision SAS for cone-specific promoter technologyAcademic collaboration includes University of Florida among others
Beyond the preview
Go deeper on Applied Genetic Technologies Corporation.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Applied Genetic Technologies Corporation.